title: Primary chemotherapy of advanced head and neck cancer: where do we go from here?
authors.forename: B S
authors.initials: BS
authors.lastname: Glisson
authors.forename: W K
authors.initials: WK
authors.lastname: Hong
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D015986:Confounding Factors, Epidemiologic; D018450:Disease Progression; D005472:Fluorouracil / Q000008:administration & dosage; D006258:Head and Neck Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy; D006801:Humans; D007275:Injections, Intravenous; D018714:Radiotherapy, Adjuvant; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D000964:Antimetabolites, Antineoplastic; D005472:Fluorouracil